1-94063218-C-T
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 2P and 16B. PM1BP4_StrongBP6_Very_StrongBS2
The NM_000350.3(ABCA4):c.1654G>A(p.Val552Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00371 in 1,614,084 control chromosomes in the GnomAD database, including 16 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V552A) has been classified as Uncertain significance.
Frequency
Consequence
NM_000350.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ABCA4 | NM_000350.3 | c.1654G>A | p.Val552Ile | missense_variant | 12/50 | ENST00000370225.4 | |
ABCA4 | XM_047416704.1 | c.1654G>A | p.Val552Ile | missense_variant | 12/49 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ABCA4 | ENST00000370225.4 | c.1654G>A | p.Val552Ile | missense_variant | 12/50 | 1 | NM_000350.3 | P1 | |
ABCA4 | ENST00000649773.1 | c.1654G>A | p.Val552Ile | missense_variant | 12/19 |
Frequencies
GnomAD3 genomes AF: 0.00239 AC: 364AN: 152126Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00269 AC: 677AN: 251436Hom.: 2 AF XY: 0.00273 AC XY: 371AN XY: 135888
GnomAD4 exome AF: 0.00385 AC: 5622AN: 1461840Hom.: 16 Cov.: 32 AF XY: 0.00383 AC XY: 2783AN XY: 727228
GnomAD4 genome AF: 0.00239 AC: 364AN: 152244Hom.: 0 Cov.: 32 AF XY: 0.00216 AC XY: 161AN XY: 74438
ClinVar
Submissions by phenotype
not provided Benign:3
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 05, 2020 | In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 29386879, 31766579, 28559085, 30718709, 29925512, 19243736, 19028736, 10958763, 22229821, 29555955, 29847635, 28118664, 26593885, 26720470, 18024811, 24265693) - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jan 01, 2024 | ABCA4: BS2 - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Retinal dystrophy Uncertain:1
Uncertain significance, flagged submission | clinical testing | Blueprint Genetics | Jun 05, 2018 | - - |
Retinitis Pigmentosa, Recessive Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jan 09, 2017 | - - |
Stargardt Disease, Recessive Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
ABCA4-related disorder Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. - |
Cone-Rod Dystrophy, Recessive Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Macular degeneration Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at